Andrew Balo
2015
In 2015, Andrew Balo earned a total compensation of $3.5M as EVP, Clinical, Regulatory and Quality at DexCom.
Compensation breakdown
| Non-Equity Incentive Plan | $379,266 |
|---|---|
| Salary | $310,000 |
| Stock Awards | $2,830,478 |
| Other | $22,524 |
| Total | $3,542,268 |
Balo received $2.8M in stock awards, accounting for 80% of the total pay in 2015.
Balo also received $379.3K in non-equity incentive plan, $310K in salary and $22.5K in other compensation.
Rankings
In 2015, Andrew Balo's compensation ranked 2,559th out of 13,638 executives tracked by ExecPay. In other words, Balo earned more than 81.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,559 out of 13,638 | 81st |
Division Manufacturing | 902 out of 5,190 | 83rd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 108 out of 760 | 86th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 62 out of 466 | 87th |
Industry Surgical and Medical Instruments and Apparatus | 34 out of 293 | 88th |
Source: SEC filing on April 6, 2016.
Balo's colleagues
We found four more compensation records of executives who worked with Andrew Balo at DexCom in 2015.